Prostatic Urethra Urothelial Carcinoma
NCI Definition: An urothelial carcinoma that arises from the urothelial lining of the prostatic urethra. 
There is 1 clinical trial for prostatic urethra urothelial carcinoma, of which 1 is open and 0 are completed or closed. Of the trial that contains prostatic urethra urothelial carcinoma as an inclusion criterion, 1 is phase 2 (1 open).
Cisplatin, doxorubicin, and methotrexate are the most common interventions in prostatic urethra urothelial carcinoma clinical trials.
2. The AACR Project GENIE Consortium. AACR Project GENIE: powering precision medicine through an international consortium. Cancer Discovery. 2017;7(8):818-831. Dataset Version 6. This dataset does not represent the totality of the genetic landscape; see paper for more information.